SEVO Bioscience

SEVO Bioscience is developing KYVAX, an oral vaccine platform for fish, aiming to disrupt the aquaculture health market by offering a cost-effective and scalable solution compared to traditional injectable vaccines.

By continuing, you agree to share your contact information with SEVO Bioscience.